AbbVie Inc.
Synthetic route to anti-viral agents
Last updated:
Abstract:
The invention provides methods of synthesizing a viral protease inhibitor in high yield, without using expensive catalysts or challenging reaction conditions.
Status:
Grant
Type:
Utility
Filling date:
17 Sep 2018
Issue date:
15 Oct 2019